ctrl K

Price Alert

Rhythm Pharmaceuticals In... (RYTM)

NASDAQ: RYTM · Real-Time Price · USD

97.20

-0.89 (-0.91%)

At close: Aug 19, 2025, 3:59 PM

97.25

0.05%

After-hours: Aug 19, 2025, 05:58 PM EDT

Rhythm Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	89.14M	60.08M	127.68M	59.25M
Short-Term Investments	231.43M	215.76M	205.61M	235.61M
Long-Term Investments	n/a	n/a	328K	328K
Other Long-Term Assets	7.79M	15.33M	16.98M	12.14M
Receivables	18.51M	14.87M	6.22M	1.02M
Inventory	18.74M	8.62M	2.92M	111K
Other Current Assets	8.8M	6.67M	11.81M	3.99M
Total Current Assets	374.2M	308.27M	354.24M	308.39M
Property-Plant & Equipment	4.11M	2.12M	3.38M	4.33M
Goodwill & Intangibles	6.17M	7.03M	7.88M	4.66M
Total Long-Term Assets	18.07M	24.48M	28.25M	21.14M
Total Assets	392.27M	332.75M	382.48M	329.52M
Account Payables	12.33M	4.88M	4.8M	5.74M
Deferred Revenue	1.29M	1.29M	1.43M	7M
Short-Term Debt	n/a	n/a	684K	606K
Other Current Liabilities	101.9M	32.82M	20.77M	21.11M
Total Current Liabilities	115.52M	55.2M	39.81M	43.43M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	108.27M	107.29M	77.15M	n/a
Total Long-Term Liabilities	112.21M	107.78M	78.41M	1.95M
Total Liabilities	227.72M	162.99M	118.22M	45.37M
Total Debt	3.94M	1.26M	1.94M	2.55M
Common Stock	61K	59K	56K	50K
Retained Earnings	-1.16B	-894.74M	-710.06M	-528.94M
Comprehensive Income	-39K	134K	-92K	-1K
Shareholders Equity	164.55M	169.76M	264.26M	284.15M
Total Investments	231.43M	215.76M	205.61M	235.61M